Piribedil for restless legs syndrome: A pilot study
Identifieur interne : 004722 ( Main/Exploration ); précédent : 004721; suivant : 004723Piribedil for restless legs syndrome: A pilot study
Auteurs : Virgilio Gerald H. Evidente [Philippines]Source :
- Movement Disorders [ 0885-3185 ] ; 2001-05.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Chemotherapy, Dopamine Agonists (administration & dosage), Dopamine Agonists (adverse effects), Dopamine agonist, Dose-Response Relationship, Drug, Female, Human, Humans, Male, Middle Aged, Pilot Projects, Piribedil, Piribedil (administration & dosage), Piribedil (adverse effects), Previous study, Receptors, Dopamine D2 (agonists), Restless Legs Syndrome (drug therapy), Restless legs syndrome, Treatment, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Dopamine Agonists, Piribedil.
- chemical , adverse effects : Dopamine Agonists, Piribedil.
- chemical , agonists : Receptors, Dopamine D2.
- drug therapy : Restless Legs Syndrome.
- Adult, Aged, Aged, 80 and over, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Pilot Projects, Treatment Outcome.
Abstract
Thirteen consecutive patients with restless legs syndrome (RLS) were treated with piribedil and were rated using an RLS rating scale (0–10) and subjective response (0–100%); 11/13 (85%) had improvement of their mean RLS scores with subjective response ranging from 30% to 100% (mean 74.6%). This pilot study suggests that piribedil is effective for RLS.
Url:
DOI: 10.1002/mds.1104
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C08
- to stream Istex, to step Curation: 001C08
- to stream Istex, to step Checkpoint: 002F49
- to stream Main, to step Merge: 006C04
- to stream PascalFrancis, to step Corpus: 002985
- to stream PascalFrancis, to step Curation: 000336
- to stream PascalFrancis, to step Checkpoint: 002930
- to stream Main, to step Merge: 006E29
- to stream PubMed, to step Corpus: 003D21
- to stream PubMed, to step Curation: 003D21
- to stream PubMed, to step Checkpoint: 003C72
- to stream Ncbi, to step Merge: 000530
- to stream Ncbi, to step Curation: 000530
- to stream Ncbi, to step Checkpoint: 000530
- to stream Main, to step Merge: 006974
- to stream Main, to step Curation: 004722
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Piribedil for restless legs syndrome: A pilot study</title><author><name sortKey="Evidente, Virgilio Gerald H" sort="Evidente, Virgilio Gerald H" uniqKey="Evidente V" first="Virgilio Gerald H." last="Evidente">Virgilio Gerald H. Evidente</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D2C857FF28808AFC38501379EF703F8F3E5B7BD4</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1002/mds.1104</idno><idno type="url">https://api.istex.fr/document/D2C857FF28808AFC38501379EF703F8F3E5B7BD4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001C08</idno><idno type="wicri:Area/Istex/Curation">001C08</idno><idno type="wicri:Area/Istex/Checkpoint">002F49</idno><idno type="wicri:doubleKey">0885-3185:2001:Evidente V:piribedil:for:restless</idno><idno type="wicri:Area/Main/Merge">006C04</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:01-0377992</idno><idno type="wicri:Area/PascalFrancis/Corpus">002985</idno><idno type="wicri:Area/PascalFrancis/Curation">000336</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002930</idno><idno type="wicri:doubleKey">0885-3185:2001:Evidente V:piribedil:for:restless</idno><idno type="wicri:Area/Main/Merge">006E29</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:11391766</idno><idno type="wicri:Area/PubMed/Corpus">003D21</idno><idno type="wicri:Area/PubMed/Curation">003D21</idno><idno type="wicri:Area/PubMed/Checkpoint">003C72</idno><idno type="wicri:Area/Ncbi/Merge">000530</idno><idno type="wicri:Area/Ncbi/Curation">000530</idno><idno type="wicri:Area/Ncbi/Checkpoint">000530</idno><idno type="wicri:doubleKey">0885-3185:2001:Evidente V:piribedil:for:restless</idno><idno type="wicri:Area/Main/Merge">006974</idno><idno type="wicri:Area/Main/Curation">004722</idno><idno type="wicri:Area/Main/Exploration">004722</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Piribedil for restless legs syndrome: A pilot study</title><author><name sortKey="Evidente, Virgilio Gerald H" sort="Evidente, Virgilio Gerald H" uniqKey="Evidente V" first="Virgilio Gerald H." last="Evidente">Virgilio Gerald H. Evidente</name><affiliation wicri:level="1"><country xml:lang="fr">Philippines</country><wicri:regionArea>St. Luke's Philippine Movement Disorders Center, St. Luke's Medical Center, Quezon City</wicri:regionArea><wicri:noRegion>Quezon City</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2001-05">2001-05</date><biblScope unit="vol">16</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="579">579</biblScope><biblScope unit="page" to="581">581</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D2C857FF28808AFC38501379EF703F8F3E5B7BD4</idno><idno type="DOI">10.1002/mds.1104</idno><idno type="ArticleID">MDS1104</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Chemotherapy</term><term>Dopamine Agonists (administration & dosage)</term><term>Dopamine Agonists (adverse effects)</term><term>Dopamine agonist</term><term>Dose-Response Relationship, Drug</term><term>Female</term><term>Human</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pilot Projects</term><term>Piribedil</term><term>Piribedil (administration & dosage)</term><term>Piribedil (adverse effects)</term><term>Previous study</term><term>Receptors, Dopamine D2 (agonists)</term><term>Restless Legs Syndrome (drug therapy)</term><term>Restless legs syndrome</term><term>Treatment</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dopamine Agonists</term><term>Piribedil</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term><term>Piribedil</term></keywords><keywords scheme="MESH" type="chemical" qualifier="agonists" xml:lang="en"><term>Receptors, Dopamine D2</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Dose-Response Relationship, Drug</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pilot Projects</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Chimiothérapie</term><term>Etude préalable</term><term>Homme</term><term>Impatience membre inférieur syndrome</term><term>Piribédil</term><term>Stimulant dopaminergique</term><term>Traitement</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Thirteen consecutive patients with restless legs syndrome (RLS) were treated with piribedil and were rated using an RLS rating scale (0–10) and subjective response (0–100%); 11/13 (85%) had improvement of their mean RLS scores with subjective response ranging from 30% to 100% (mean 74.6%). This pilot study suggests that piribedil is effective for RLS.</div></front></TEI><affiliations><list><country><li>Philippines</li></country></list><tree><country name="Philippines"><noRegion><name sortKey="Evidente, Virgilio Gerald H" sort="Evidente, Virgilio Gerald H" uniqKey="Evidente V" first="Virgilio Gerald H." last="Evidente">Virgilio Gerald H. Evidente</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004722 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004722 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D2C857FF28808AFC38501379EF703F8F3E5B7BD4
|texte= Piribedil for restless legs syndrome: A pilot study
}}
| This area was generated with Dilib version V0.6.23. |  |